Risk factors to take into account in prediabetes
Keywords:
diabetes, risk factorsAbstract
Prediabetes (PDM) is considered an intermediate stage between normoglycemia and diabetes (DM), it represents a significant risk factor for progression to DM, and also for the appearance of both macro and microvascular complications. There is strong evidence that GA constitutes an increasing, curvilinear and progressive risk for the development of diabetes. The study by Nichols et al. showed that for each mg/dl increase in GA, the risk of DM increases by 6%, after controlling other risk factors, comparing patients with GA less than 85 mg/ dl, vs subjects with GA levels of 95 to 99 mg/dl with a Hazard Ratio (HR)=2.33 (95% CI, 1.95-2.79; p<0.0001) of developing DM1.
Other risk factors associated with prediabetes to take into account are age over 35 years, having a first-degree relative with diabetes, race and ethnic origin with a greater predisposition (African American, Latino, Native American, Asian American, Pacific Islander), history of gestational diabetes, history of cardiovascular disease, clinical conditions associated with insulin resistance, obesity, dyslipidemia (high triglycerides >250 mg/dl and/or low HDL cholesterol <35 mg/dl), arterial hypertension, polycystic ovary syndrome, physical inactivity, high-risk medications, history of pancreatitis, fatty liver, alcohol consumption, smoking, people with HIV2.
Intervention studies have shown that type 2 diabetes can be effectively prevented or delayed in high-risk individuals3-4.
Our main task and challenge will be to identify those who would benefit from early detection and interventions to prevent or delay the onset of type 2 diabetes and its complications.
References
I. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med 2008 Jun;121(6):519-24. doi: 10.1016/j.amjmed.2008.02.026. PMID: 18501234.
II. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes 2024. Diabetes Care 2024;47(Suppl. 1):S43-S51. doi: 10.2337/dc24- S003
III. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
IV. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care1997;20:537-544.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Society of Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.